Yannick Vancoppenolle

reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.

Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland.

Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium.

Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France.

Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium.

Centre d'Entreprise et d'Innovation de Louvain-La-Neuve NV provides advice and consultancy services for small and medium sized businesses. The firm is a launch base for start-ups and supports the created business during the first years of development. The company was founded on April 22, 2004 and is headquartered in Louvain-La-Neuve, Belgium.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

AnimAb BV is a Belgian company that focuses on improving animal performance through its antibody-based approach that targets intestinal pathogens. AnimAb is based in Ghent, Belgium. The company helps protect piglets during their most fragile post-weaning stage. AnimAb integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies, and sustainability. The company's technology prevents intestinal bacterial colonization thanks to the direct integration with animal feed. The company's cross-disciplinary science teams developed a new antibody technology designed for oral ingestion based on a scalable, cost-effective microbial production process. The company was founded in 2020 by Eric Cox, Henri de Greve, Ann Depicker, and Nico Callewaert. Alain Wille has been the CEO of the company since 2020.

c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany.

Aphea.Bio SA engages in research and development of biotechnology and agricultural products. It develops next generation biopesticides and biostimulants based on natural microorganisms. The company was founded by Isabel Vercauteren and Steven Vandenabeele in December 5, 2016 and is headquartered in Ghent, Belgium.

Etablissementen Adriaens SA engages in the operation of a slaughterhouse for pork and beef processing. The company was founded on November 17, 1960 and is headquartered in Zottegem, Belgium.

Compagnie Le Zoute NV is a Belgian company that operates hotels. The private company is based in Knokke-Heist, Belgium and has subsidiaries in Belgium. The company was founded in 1931.

Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.

Part of Maatschappij voor Roerend Bezit van de Boerenbond CVBA, Aktiefinvest CVBA is a Belgian company that provides real estate services. The company is based in Louvain, Belgium and was founded in 1990.

Aveve NV supplies agricultural and horticultural products. The firm specializes in farming industry, retail, agriculture, horticulture and animal feed. The company was founded by John F. Mellaerts on July 20, 1890 and is headquartered in Leuven, Belgium.

Caloritum NV offers innovative technology to industrial customers. The firm provides transform wasted heat into useful process heat and reduces the total energy bill by saving fossil fuels and CO2 emissions. The company was founded by Wouter Ducheyne and Christian Heeren in 2012 and is headquartered in Antwerp, Belgium.

Ifast NV develops and commercializes intellectual property, technology and know-how related to the organoleptic and functional properties of foods and beverages. It offers services to the corporate and public sectors. The company was founded by Pascal Mertens in 2012 and is headquartered in Roosdaal, Belgium.

ArtiQ NV engages in the design and manufacture of respiratory medicine, medical devices, and artificial intelligence. The company was founded by Marko Topalovic, Bart Swaelens, Wim Janssens and Marc Decramer in 2019 and is headquartered in Leuven, Belgium.

DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.

ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium.

Porphyrio NV engages in the development of management software solutions for the agricultural sector. It offers Smart Farm Assistant , Smart Broiler Chain Optimizer, Lay-Insight, and Broiler-Insight. The company was founded by Bart Kemps and Kristof Mertens on August 03, 2013 and is headquartered in Herent, Belgium.

Pulsify Medical BV is a Belgian digital medical technology company that specializes in developing wearable ultrasound patches. The company is based in Louvain, Belgium. Pulsify Medical was founded in 2019 by Lieven Herbots, Xavier Rottenberg, Jan D'hooge, Steve Stoffels. Iwan van Vijfeijken has been the CEO of the company since 2019.

Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium.

Part of SC Group, Inc., Stonehaven Consulting AG is a Swiss company that provides life sciences management consulting services. The company is based in Frauenfeld, Switzerland. The company was founded in 2015 by George C. Gunn, Paddy Holahan. The CEO is Matthias Manuel Hofer.

The Royal College of Veterinary Surgeons is an organization that provides information on the outcomes of disciplinary hearings against veterinarians and registered veterinary nurses. The information includes announcements, charges, findings, reasons, decisions, judgments, and press releases.

Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX.

Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway.

PHARMAQ AS operates as a veterinary pharmaceutical company. It provides health products to the global aquaculture industry. The company was founded on July 23, 2004 and is headquartered in Overhalla, Norway.

Nuritas Ltd. provides bioinformatics technology services. It offers products for human health and nutrition, cosmetics and personal care, animal health and nutrition. The firm’s disruptive approach to discovery combines artificial intelligence and DNA analysis to data-mine billions of molecules. The company was founded by Nora Khaldi and is headquartered in Dublin, Ireland.